Company Overview of Versant Ventures, Inc.
Versant Ventures is a venture capital firm specializing in incubation, seed, start-ups, and early stage investments. It seeks to invest in all segments of healthcare including, medical devices and diagnostics; med-tech; life sciences that include biopharmaceuticals and biotechnology platforms; healthcare services; and healthcare information technology. The firm prefers to invest in companies based in the United States and Western Europe. The firm seeks to invest in the biotechnology sector in Canada. The firm typically invests between $10 million and $20 million into each startup before it’s sold or goes public. It will not invest in a company unless it has at least $500 million in annualize...
3000 Sand Hill Road
Menlo Park, CA 94025
Founded in 1999
Key Executives for Versant Ventures, Inc.
Co-Founder and Managing Director
Compensation as of Fiscal Year 2014.
Versant Ventures, Inc. Key Developments
Roche, Inception Sciences, and Versant Ventures to Collaborate on MS Research
Jun 25 14
Roche (Switzerland) has entered into a partnership with Inception Sciences (US) and Versant Ventures (US) for the formation of a new company, Inception 5, which will focus on research and development of novel treatments for multiple sclerosis (MS). Inception 5 will research multiple molecular targets for remyelination that have already been identified, building a remyelination screening platform developed by investigators at the University of California.
Versant Ventures Expands Canadian Operations with Launch of Inception Sciences in Montreal
Jun 24 14
Versant Ventures continues its Canadian growth strategy with the launch of biopharmaceutical incubator Inception Sciences in Montreal. Versant, with Inception Sciences, will be working to launch new companies that can accelerate the commercialization of scientific research in the province of Quebec. Inception Sciences Montreal is another major commitment by Versant in Canada in the past year, following the launch of Blueline Bioscience in Toronto and Inception Sciences Vancouver. The launch of Montreal operations also adds a third research site to its Inception Sciences discovery engine to address the growing appetite of major pharmaceutical companies to enter innovative venture-backed partnerships. Inception Sciences Montreal is one of a number of recent activities for Versant in Canada. Versant recently formed a biotechnology incubator in Toronto, called Blueline Bioscience, which is collaborating with Celgene and aims to launch new companies in areas such as oncology and inflammation. Blueline Bioscience is headquartered in the MaRS Discovery District of Toronto and will announce the launch of its first spin out company in the next several months. In Vancouver, Versant established an office in 2013 and backed an Inception Sciences unit that is partnering with Bayer Healthcare to develop innovative therapeutics for retinal eye disease.
Versant Ventures, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 04:15 PM
Jun 11 14
Versant Ventures, Inc. Presents at Washington Biotechnology & Biomedical Association 14th Annual Life Science Innovation Northwest 2014, Jun-19-2014 04:15 PM. Venue: Washington State Convention Center, Seattle, Washington, United States. Speakers: Stefan Mathias Larson, Entrepreneur-in-Residence.
Similar Private Companies By Industry
Recent Private Companies Transactions